New device aims to tackle glaucoma while fixing cataracts
NCT ID NCT05696561
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early study tests a new surgical tool that opens up the eye's natural drainage channels to lower pressure in people with open-angle glaucoma who are also having cataract surgery. About 70 participants will receive the device during their cataract procedure. The main goal is to see if it safely reduces eye pressure without the need for daily drops.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Canaloplasty device (surgical tool)
- What this could lead to
- If successful, this device could offer a new, safer way to lower eye pressure in glaucoma patients during cataract surgery, reducing the need for daily eye drops.
- What could go wrong
- This is a very early, first-in-human trial with only 70 participants. The device may not work as expected or could cause complications like infection or temporary vision changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OAG - OPEN-ANGLE GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centro Oftalmologico Robles
NOT_YET_RECRUITINGSanta Rosa de Copán, Honduras
-
Centro de la Vision
RECRUITINGSantiago, Chile
-
Clínica 20/20
RECRUITINGSan José, Costa Rica
More trials for these conditions
Other studies related to the condition(s) this trial covers.